Terminated NA INTERVENTIONAL 1-arm NCT01644526

A Pilot Study To Evaluate The CreatiVasc Hemoaccess Valve System In Patients Requiring Arteriovenous Graft Placement

Sponsor: Diaxamed LLC

Updated 8 times since 2017 Last updated: Jan 31, 2018 Started: Jan 31, 2016 Primary completion: Jun 30, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

An enhanced device has been developed

Other End Stage Renal Disease trials with similar outcome

Browse all End Stage Renal Disease trials

A NA clinical study on End Stage Renal Disease, this trial is terminated or withdrawn. The trial is conducted by Diaxamed LLC and has accumulated 8 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Mar 2018 — Jun 2018 [monthly]

Terminated NA

▶ Show 3 earlier versions

Oct 2017 — Mar 2018 [monthly]

Terminated NA

Status: Unknown Status → Terminated · Phase: PHASE1 → NA
Feb 2017 — Oct 2017 [monthly]

Unknown Status PHASE1
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE1

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diaxamed LLC

Data source: Diaxamed LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Greenville, United States